Sabadell Asset Management’s Pfizer PFE Stock Holding History

Sabadell Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$10.1M	Buy	276,776 +30,704	+12%	+$1.2M	2.11%	15
2023 Q1	$10.2M	Sell	246,072 -6,459	-3%	-$279K	2.17%	12
2022 Q4	$12M	Sell	252,531 -1,254	-0.5%	-$60.1K	2.49%	6
2022 Q3	$11.2M	Buy	253,785 +24,926	+11%	+$1.21M	2.47%	7
2022 Q2	$11.8M	Buy	228,859 +80,455	+54%	+$4.1M	2.48%	7
2022 Q1	$8.19M	Sell	148,404 -82,188	-36%	-$4.26M	1.41%	16
2021 Q4	$12.8M	Buy	230,592 +3,670	+2%	+$182K	2.05%	10
2021 Q3	$9.76M	Buy	226,922 +132,709	+141%	+$5.88M	1.68%	13
2021 Q2	$3.69M	Buy	+94,213	New	+$3.66M	0.64%	49

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sabadell Asset Management's PFE Position: Q2 2023 in Review

Sabadell Asset Management increased its Pfizer (PFE) stake by 12% in Q2 2023, buying an estimated $1.2M and bringing the position to 276,776 shares worth $10.1M. The position accounts for 2.11% of the portfolio, ranked #15.

Sabadell Asset Management first reported a position in PFE in Q2 2021 and has held it in 9 quarters since. The position peaked at $12.8M in Q4 2021. 3,042 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Sabadell Asset Management held 276,776 shares of Pfizer worth $10.1M as of Q2 2023.
Sabadell Asset Management bought 30,704 Pfizer shares in Q2 2023, an estimated $1.2M.
Pfizer made up 2.11% of Sabadell Asset Management's portfolio in Q2 2023, its #15 holding.
Sabadell Asset Management first reported a position in Pfizer in Q2 2021 and has held it in 9 quarters since.
Sabadell Asset Management's Pfizer position peaked at $12.8M in Q4 2021.
3,042 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Sabadell Asset Management's 13F filing for Q2 2023, filed 23 Jan 2024.